In vitro differential phenotypic characteristics among type-ii toxoplasma gondii strains from congenital toxoplasmosis in humans

Journal of Parasitology

Volumn 96, Issue 4, 2010, Pages 798-799

  Brenier Pinchart, M P ^a   Bertini, R L ^a   Maubon, D ^a   Pelloux, H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE INCIDENCE; INFECTIVITY; PARASITE INFESTATION; PHENOTYPE; PROTOZOAN;

ARTICLE; CELL INVASION; CONGENITAL TOXOPLASMOSIS; CYST; EUROPE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PARASITE ISOLATION; PHENOTYPE; PHENOTYPIC VARIATION; STRAIN DIFFERENCE; STRAIN IDENTIFICATION; SYMPTOM; TOXOPLASMA GONDII;

ANALYSIS OF VARIANCE; ANIMALS; CELLS, CULTURED; FIBROBLASTS; HUMANS; INTERFERON-GAMMA; MICE; PHENOTYPE; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL; VIRULENCE;

TOXOPLASMA GONDII;

EID: 77956139653     PISSN: 00223395     EISSN: 19372345     Source Type: Journal    
DOI: 10.1645/GE-2405.1     Document Type: Article

References (17)

1. AJZENBERG, D., N. COGNE, L. PARIS, M. H. BESSIÈRES, P. THULLIEZ, D. FILISETTI, H. PELLOUX, P. MARTY, AND M. L. DARDÉ. 2002. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis and correlation with clinical findings. Journal of Infectious Diseases 186: 684-689.
2. ̀RES,D. QUINIO,ET AL 2009, Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immu-nocompromised patients and correlation with clinical findings, Journal of Infectious Diseases,199,1155- 1167.
3. AMBROISE-THOMAS, P., M. SCHWEITZER, J. M. PINON, AND O. THIEBAU-GEORGES. 2001. Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow-up. Bulletin de l'Académie Nationale de Médecine 185: 665-683.
4. ANTINORI, A., D. LARUSSA, A. CINGOLANI, P. LORENZINI, S. BOSSOLASCO, M. G. FINAZZI, M. BONGIOVANNI, G. GUARALDI, S. GRISETTI, B. VIGO ET AL. 2004. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Clinical Infectious Diseases 39: 1681-1691.
5. ARAUJO, F. G., AND T. SLIFER. 2003. Different strains of Toxoplasma gondii induce different cytokine responses in CBA/Ca mice. Infection and Immunity 71: 4171-4174.
6. BRENIER-PINCHART, M. P., I. VILLENA, C. MERCIER, F. DUrAND, J. SIMON, M. F. CESBRON-DELAUW, AND H. PELLOUX. 2006. The Toxoplasma surface protein SAG1 triggers efficient in vitro secretion of chemokine ligand 2 (CCL2) from human fibroblast. Microbes and Infection 8: 254-261.
7. DEROUIN, F., H. PELLOUX, AND ESCMID STUDY GROUP ON CLINICAL PARASITOLOGY. 2008. Prevention of toxoplasmosis in transplant patients. Clinical Microbiology and Infection 14: 1089-1101.
8. FAGARD, R., H. VAN TAN, C. CREUZET, AND H. PELLOUX. 1999. Differential development of Toxoplasma gondii in neural cells. Parasitology Today 15: 504-507.
9. LALIBERTÉ, J., AND V. B. CARRUTHERS. 2008. Host cell manipulation by the human pathogen Toxoplasma gondii. Cellular and Molecular Life Sciences 65: 1900-1915.
10. MARTINO, R., J. MAERTENS, S. BRETAGNE, M. ROVIRA, E. DECONINCK, A. J. ULLMANN, T. HELD, AND C. CORDONNIER. 2000. Toxoplasmosis after hematopoietic stem cell transplantation. Clinical Infectious Diseases 31: 1188-1195.
11. MAUBON, D., D. AJZENBERG, M. P. BRENIER-PINCHART, M. L. DARDÉ, AND H. PELLOUX. 2008. What are the respective host and parasite contributions to toxoplasmosis? Trends in Parasitology 24: 299-303.
12. MENECEUR, P., M. A. BOULDOUYRE, D. AUBERT, I. VILLENA, J. MENOTTI, V. SAUVAGE, J. F. GARIN, AND F. DEROUIN. 2008. In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone. Antimicrobial Agents and Chemotherapy 52: 1269-1277.
13. MONTOYA, J. G., AND J. S. REMINGTON. 2008. Management of Toxoplasma gondii infection during pregnancy. Clinical Infectious Diseases 47: 554-566.
14. PEYRON, F., N. EUDES, F. DE MONBRISON, M. WALLON, AND S. PICOT. 2004. Fitness of Toxoplasma gondii is not related to DHFR single-nucleotide polymorphism during congenital toxoplasmosis. International Journal for Parasitology 34: 1169-1175.
15. SAEIJ, J. P. J., J. P. BOYLE, AND C. BOOTHROYD. 2005. Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends in Parasitology 21: 476-481.
16. SUZUKI, Y. 2002. Host resistance in brain against Toxoplasma gondii. Journal of Infectious Diseases 185: S58-S65.
17. ̀TE, C. ANSEL, D. CAMUS, AND J. F. DUBREMETZ. 1991. Characterization of bradyzoite-specific antigens of Toxoplasma gondii. Infection and Immunity 59: 3750-13573